228 related articles for article (PubMed ID: 29271876)
1. GE11 Peptide as an Active Targeting Agent in Antitumor Therapy: A Minireview.
Genta I; Chiesa E; Colzani B; Modena T; Conti B; Dorati R
Pharmaceutics; 2017 Dec; 10(1):. PubMed ID: 29271876
[TBL] [Abstract][Full Text] [Related]
2. GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation.
Cheng L; Huang FZ; Cheng LF; Zhu YQ; Hu Q; Li L; Wei L; Chen DW
Int J Nanomedicine; 2014; 9():921-35. PubMed ID: 24611009
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory Effect of Oxaliplatin-loaded Engineered Milk Extracellular Vesicles on Tumor Progression.
Go G; Park HJ; Lee JH; Yun CW; Lee SH
Anticancer Res; 2022 Feb; 42(2):857-866. PubMed ID: 35093883
[TBL] [Abstract][Full Text] [Related]
4. EGFR-targeting peptide conjugated polymer-lipid hybrid nanoparticles for delivery of salinomycin to osteosarcoma.
Du L; Xu Y; Han B; Wang Y; Zeng Q; Shao M; Yu Z
J Cancer Res Ther; 2023 Dec; 19(6):1544-1551. PubMed ID: 38156920
[TBL] [Abstract][Full Text] [Related]
5. Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment.
Hailing T; Yonghong P; Yufeng Z; Haitao T
J Control Release; 2022 Sep; 349():592-605. PubMed ID: 35872181
[TBL] [Abstract][Full Text] [Related]
6. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
[TBL] [Abstract][Full Text] [Related]
7. GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers.
Xu WW; Liu DY; Cao YC; Wang XY
Int J Nanomedicine; 2017; 12():6461-6470. PubMed ID: 28919747
[TBL] [Abstract][Full Text] [Related]
8. Design of smart GE11-PLGA/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in vitro/ex vivo characterization.
Colzani B; Speranza G; Dorati R; Conti B; Modena T; Bruni G; Zagato E; Vermeulen L; Dakwar GR; Braeckmans K; Genta I
Int J Pharm; 2016 Sep; 511(2):1112-23. PubMed ID: 27511710
[TBL] [Abstract][Full Text] [Related]
9. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo.
Fang Y; Yang W; Cheng L; Meng F; Zhang J; Zhong Z
Acta Biomater; 2017 Dec; 64():323-333. PubMed ID: 29030307
[TBL] [Abstract][Full Text] [Related]
10. GE11 Peptide Conjugated Liposomes for EGFR-Targeted and Chemophotothermal Combined Anticancer Therapy.
Huang X; Chen L; Zhang Y; Zhou S; Cai HH; Li T; Jin H; Cai J; Zhou H; Pi J
Bioinorg Chem Appl; 2021; 2021():5534870. PubMed ID: 33868396
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor targeted methotrexate and small interfering RNA co-delivery.
Steinborn B; Truebenbach I; Morys S; Lächelt U; Wagner E; Zhang W
J Gene Med; 2018 Jul; 20(7-8):e3041. PubMed ID: 29949222
[TBL] [Abstract][Full Text] [Related]
12. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
[TBL] [Abstract][Full Text] [Related]
13. Exploring pitfalls of
Striese F; Sihver W; Gao F; Bergmann R; Walther M; Pietzsch J; Steinbach J; Pietzsch HJ
Amino Acids; 2018 Oct; 50(10):1415-1431. PubMed ID: 30039310
[TBL] [Abstract][Full Text] [Related]
14. Intra-Articular Formulation of GE11-PLGA Conjugate-Based NPs for Dexamethasone Selective Targeting-In Vitro Evaluation.
Chiesa E; Pisani S; Colzani B; Dorati R; Conti B; Modena T; Braekmans K; Genta I
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30082640
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor-targeted peptide conjugated phospholipid micelles for doxorubicin delivery.
Fan M; Liang X; Yang D; Pan X; Li Z; Wang H; Shi B
J Drug Target; 2016; 24(2):111-9. PubMed ID: 26176268
[TBL] [Abstract][Full Text] [Related]
16. GE11-antigen-loaded hepatitis B virus core antigen virus-like particles efficiently bind to TNBC tumor.
Zhang L; Tang L; Jiang Y; Wang C; Huang L; Ding T; Zhang T; Li H; Xie L
Front Oncol; 2023; 13():1110751. PubMed ID: 37020877
[TBL] [Abstract][Full Text] [Related]
17. Enhanced tumor-targeted gene delivery by bioreducible polyethylenimine tethering EGFR divalent ligands.
Lee D; Lee YM; Kim J; Lee MK; Kim WJ
Biomater Sci; 2015 Jul; 3(7):1096-104. PubMed ID: 26221943
[TBL] [Abstract][Full Text] [Related]
18. GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer Cells.
Li K; Pang L; Pan X; Fan S; Wang X; Wang Q; Dai P; Gao W; Gao J
Technol Cancer Res Treat; 2021; 20():15330338211004954. PubMed ID: 34056977
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of [
Li X; Hu K; Liu W; Wei Y; Sha R; Long Y; Han Y; Sun P; Wu H; Li G; Tang G; Huang S
Nucl Med Biol; 2020; 90-91():84-92. PubMed ID: 33189948
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Analysis of
Paiva I; Mattingly S; Wuest M; Leier S; Vakili MR; Weinfeld M; Lavasanifar A; Wuest F
Mol Pharm; 2020 May; 17(5):1470-1481. PubMed ID: 32233491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
